
Sign up to save your podcasts
Or


Episode 377
Considered too dangerous and unreliable a few years ago, the technology for gene editing babies is advancing fast. Improved methods of using CRISPR gene editing are making the technique safer and more targeted. But does that mean we should be creating designer babies?
A new, more powerful version of CRISPR has already saved lives by correcting cells in children linked to leukaemia. But editing human embryos is a different story - and less safe. Despite this, researchers have been studying whether it’s possible.
To discuss the obstacles that still need to be overcome and the ethical challenges, Rowan Hooper is joined by reporter Michael Le Page.
To read more about these stories, visit https://www.newscientist.com/
Learn more about your ad choices. Visit megaphone.fm/adchoices
By New Scientist4.4
9292 ratings
Episode 377
Considered too dangerous and unreliable a few years ago, the technology for gene editing babies is advancing fast. Improved methods of using CRISPR gene editing are making the technique safer and more targeted. But does that mean we should be creating designer babies?
A new, more powerful version of CRISPR has already saved lives by correcting cells in children linked to leukaemia. But editing human embryos is a different story - and less safe. Despite this, researchers have been studying whether it’s possible.
To discuss the obstacles that still need to be overcome and the ethical challenges, Rowan Hooper is joined by reporter Michael Le Page.
To read more about these stories, visit https://www.newscientist.com/
Learn more about your ad choices. Visit megaphone.fm/adchoices

883 Listeners

5,528 Listeners

1,921 Listeners

603 Listeners

770 Listeners

548 Listeners

963 Listeners

413 Listeners

411 Listeners

759 Listeners

732 Listeners

216 Listeners

852 Listeners

364 Listeners

476 Listeners

1 Listeners

9 Listeners

8 Listeners

2 Listeners